Today we continue our podcast series with a leading figure in the pharmaceutical technology market, Mike Nolte. Mike has a background of c.15 years in medtech, having also worked in major strategic consultancy environments. He now leads Signant Health as Chief Executive Officer, a world leading organisation in eCOA, IRT, eConsent, patient engagement and wider clinical trials support. In this podcast, Mike discusses his view on the possible implications of Covid-19 on the pharmaceutical technology market.

Listen to the Podcast below: